68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate

被引：8
|
作者：
Qiu, Shuang [1 ]
Dong, Aisheng [1 ]
Zhu, Yan [2 ]
Zuo, Changjing [1 ]
机构：
[1] Navy Med Univ, Changhai Hosp, Dept Nucl Med, 168 Changhai Rd, Shanghai 200433, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期
关键词：
prostatic ductal adenocarcinoma; PSMA; FDG; PET/CT;
D O I：
10.1097/RLU.0000000000004230
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Prostatic ductal adenocarcinoma is an uncommon variant of prostatic carcinoma with aggressive behavior and worse prognosis. We describe Ga-68-PSMA-11 and FDG PET/CT findings in a case of prostatic ductal adenocarcinoma with pelvic lymph node metastases. The majority of the prostate tumor and all the metastatic lesions showed no significant PSMA uptake but intense FDG uptake. The role of PSMA and FDG PET in the management of prostatic ductal adenocarcinoma needs to be investigated in a large number of patients.
引用
收藏
页码：836 / 838
页数：3
相关论文
共 50 条
  • [1] Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT
    Weitzer, Friedrich
    Nazerani-Hooshmand, Tina
    Aigner, Reingard Maria
    Pernthaler, Birgit
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : E358 - E359
  • [2] The additional value of 18F-FDG PET/CT compared to 68Ga-PSMA-11 PET/CT in initial diagnosed prostate cancer patients
    Wang, Yining
    Liu, Jianjun
    Chen, Ruohua
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [3] 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma
    Ergul, Nurhan
    Gunes, Burcak Yilmaz
    Yucetas, Ugur
    Toktas, Mahmut Gokhan
    Cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (12) : E422 - E427
  • [4] 68Ga-PSMA PET/CT and 18F-FDG PET/CT in the diagnosis of prostatic ductal cancer
    Huang, Haijun
    Zou, Sijuan
    Wan, Jie
    Zeng, Xing
    Wang, Shaogang
    Hu, Zhiquan
    Zhu, Xiaohua
    Yang, Chunguang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 448E9 - 448E16
  • [5] Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma
    Perez, Paola M.
    Flavell, Robert R.
    Kelley, Robin K.
    Umetsu, Sarah
    Behr, Spencer C.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (03) : e133 - e135
  • [6] Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach
    Miceli, Alberto
    Riondato, Mattia
    D'Amico, Francesca
    Donegani, Maria Isabella
    Piol, Nataniele
    Mora, Marco
    Spina, Bruno
    Morbelli, Silvia
    Bauckneht, Matteo
    MEDICINA-LITHUANIA, 2021, 57 (09):
  • [7] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [8] Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT
    Pernthaler, Birgit
    Nazerani Hooshmand, Tina
    Igrec, Jasminka
    Kvaternik, Herbert
    Aigner, Reingard M.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : E231 - E232
  • [9] Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT
    Parida, Girish Kumar
    Tripathy, Sarthak
    Gupta, Shreya Datta
    Singhal, Abhinav
    Kumar, Rakesh
    Bal, Chandrasekhar
    Shamim, Shamim Ahmed
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 248 - 249
  • [10] 18F-FDG PET/CT Versus 68Ga-PSMA-11 PET/CT in Evaluation of Distant Metastatic Disease in Recurrent Renal Cell Carcinoma
    Parghane, Rahul, V
    Basu, Sandip
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2023, 51 (03) : 261 - 262
12345